NewcelX Ltd. (NCEL)
$2.84-2.07%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- 0.93
- P/E (TTM)
- 8.61
- Short % float
- 2.17%
- Days to cover
- 1.6
- SI change
- -34.9%
- 1W
- -4.05%
- 1M
- -13.41%
- vs SPY 1W
- -3.92%
- vs SPY 1M
- -15.92%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NCEL?
- LOPJLB’s latest quantitative signal on NewcelX Ltd. (NCEL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NCEL in?
- NewcelX Ltd. (NCEL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does NewcelX Ltd. (NCEL) do?
- NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.